| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.00055 | 1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.00033 | 1 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00031 | 1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.00012 | 1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -9.8e-05 | 1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -3.5e-05 | 1 |